microRNA-144: the ‘what’ and ‘how’ of remote ischemic conditioning?

Basic Research in Cardiology

Volumn 109, Issue 5, 2014, Pages

  Przyklenk, Karin ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN144 MICRORNA, HUMAN; MIRN144 MICRORNA, MOUSE;

ANIMAL; BLOOD; HEART INFARCTION PREVENTION; HUMAN; METABOLISM; REPERFUSION INJURY;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICRORNAS; MYOCARDIAL REPERFUSION INJURY;

EID: 84905314470     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-014-0429-6     Document Type: Editorial

References (40)

1. Baars T, Skyschally A, Klein-Hitpass L, Cario E, Erbel R, Heusch G, Kleinbongard P (2014) microRNA expression and its potential role in cardioprotection by ischemic postconditioning in pigs. Pflugers Arch. doi:10.1007/s00424-013-1429-3
2. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727–734. doi:10.1016/S0140-6736(09)62001-8
3. Brandenburger T, Grievink H, Heinen N, Barthel F, Huhn R, Stachuletz F, Kohns M, Pannen B, Bauer I (2014) Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo. Shock. doi:10.1097/SHK.0000000000000201
4. Davidson SM, Selvaraj P, He D, Boi-Doku C, Yellon RL, Vicencio JM, Yellon DM (2013) Remote ischaemic preconditioning involves signalling through the SDF-1alpha/CXCR4 signalling axis. Basic Res Cardiol 108:377. doi:10.1007/s00395-013-0377-6
5. Davies WR, Brown AJ, Watson W, McCormick LM, West NE, Dutka DP, Hoole SP (2013) Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv 6:246–251. doi:10.1161/CIRCINTERVENTIONS.112.000184
6. Dickson EW, Blehar DJ, Carraway RE, Heard SO, Steinberg G, Przyklenk K (2001) Naloxone blocks transferred preconditioning in isolated rabbit hearts. J Mol Cell Cardiol 33:1751–1756. doi:10.1006/jmcc.2001.1436
7. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, Gysembergh A, Przyklenk K (1999) Rabbit heart can be “preconditioned” via transfer of coronary effluent. Am J Physiol 277:H2451–H2457
8. Duan X, Ji B, Wang X, Liu J, Zheng Z, Long C, Tang Y, Hu S (2012) Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolated rat heart model. Cardiology 122:36–43. doi:10.1159/000338149
9. Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas E, Ferdinandy P (2014) Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol. doi:10.1016/j.yjmcc.2014.01.004
10. Gourine A, Gourine AV (2014) Neural mechanisms of cardioprotection. Physiology (Bethesda) 29:133–140. doi:10.1152/physiol.00037.2013
11. Gross ER, Hsu AK, Urban TJ, Mochly-Rosen D, Gross GJ (2013) Nociceptive-induced myocardial remote conditioning is mediated by neuronal gamma protein kinase C. Basic Res Cardiol 108:381. doi:10.1007/s00395-013-0381-x
12. Hausenloy DJ, Candilio L, Laing C, Kunst G, Pepper J, Kolvekar S, Evans R, Robertson S, Knight R, Ariti C, Clayton T, Yellon DM, Investigators ET (2012) Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol 101:339–348. doi:10.1007/s00392-011-0397-x
13. He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, Xie B, Gao XG, Wang YW (2011) Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 18:22. doi:10.1186/1423-0127-18-22
14. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166–175. doi:10.1016/S0140-6736(12)60916-7
15. Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, Lamon D, Furber A, Pinet F, Prunier F (2013) Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning. PLoS One 8:e77211. doi:10.1371/journal.pone.0077211
16. Iaconetti C, Gareri C, Polimeni A, Indolfi C (2013) Non-coding RNAs: the “dark matter” of cardiovascular pathophysiology. Int J Mol Sci 14:19987–20018. doi:10.3390/ijms141019987
17. Jones WK, Fan GC, Liao SY, Zhang JM, Wang Y, Weintraub NL, Kranias EG, El Schultz J, Lorenz J, Ren XP (2009) Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling. Circulation 120:S1–S9. doi:10.1161/circulationaha.108.843938
18. Karunakaran D, Rayner KJ (2013) MicroRNAs in cardiovascular health: from order to disorder. Endocrinology 154:4000–4009. doi:10.1210/en.2013-1299
19. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106:2881–2883. doi:10.1161/01.CIR.0000043806.51912.9B
20. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
21. Li J, Rohailla S, Gelber N, Rutka J, Sabah N, Gladstone RA, Wei C, Hu P, Kharbanda RK, Redington AN (2014) MicroRNA-14 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol
22. Li J, Xu J, Cheng Y, Wang F, Song Y, Xiao J (2013) Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire? J Cell Mol Med 17:1363–1370. doi:10.1111/jcmm.12148
23. Merlocco AC, Redington KL, Disenhouse T, Strantzas SC, Gladstone R, Wei C, Tropak MB, Manlhiot C, Li J, Redington AN (2014) Transcutaneous electrical nerve stimulation as a novel method of remote preconditioning: in vitro validation in an animal model and first human observations. Basic Res Cardiol 109:406. doi:10.1007/s00395-014-0406-0
24. Meybohm P, Zacharowski K, Cremer J, Roesner J, Kletzin F, Schaelte G, Felzen M, Strouhal U, Reyher C, Heringlake M, Schon J, Brandes I, Bauer M, Knuefermann P, Wittmann M, Hachenberg T, Schilling T, Smul T, Maisch S, Sander M, Moormann T, Boening A, Weigand MA, Laufenberg R, Werner C, Winterhalter M, Treschan T, Stehr SN, Reinhart K, Hasenclever D, Brosteanu O, Bein B (2012) Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial–the RIPHeart-study. Eur Heart J 33:1423–1426
25. Ovize M, Thibault H, Przyklenk K (2013) Myocardial conditioning: opportunities for clinical translation. Circ Res 113:439–450. doi:10.1161/CIRCRESAHA.113.300764
26. Pan Z, Sun X, Ren J, Li X, Gao X, Lu C, Zhang Y, Sun H, Wang Y, Wang H, Wang J, Xie L, Lu Y, Yang B (2012) miR-1 exacerbates cardiac ischemia–reperfusion injury in mouse models. PLoS one 7:e50515. doi:10.1371/journal.pone.0050515
27. Przyklenk K (2013) Reduction of myocardial infarct size with ischemic “conditioning”: physiologic and technical considerations. Anesth Analg 117:891–901. doi:10.1213/ANE.0b013e318294fc63
28. Przyklenk K (2014) Role of extracellular vesicles in remote ischemic preconditioning: ‘good things come in small packages’? J Mol Cell Cardiol 69:83–84. doi:10.1016/j.yjmcc.2014.01.020
29. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:893–899. doi:10.1161/01.CIR.87.3.893
30. Przyklenk K, Whittaker P (2013) Genesis of remote conditioning: action at a distance—’hypotheses non fingo’? J Cardiovasc Med (Hagerstown) 14:180–186. doi:10.2459/JCM.0b013e328358c8eb
31. Przyklenk K, Whittaker P (2011) Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. J Cardiovasc Pharmacol Ther 16:255–259. doi:10.1177/1074248411409040
32. Sala V, Bergerone S, Gatti S, Gallo S, Ponzetto A, Ponzetto C, Crepaldi T (2014) MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. Cell Mol Life Sci 71:1439–1452. doi:10.1007/s00018-013-1504-0
33. Sayed AS, Xia K, Salma U, Yang T, Peng J (2014) Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ 23:503–510. doi:10.1016/j.hlc.2014.01.001
34. Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G (2013) Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382:597–604. doi:10.1016/S0140-6736(13)61450-6
35. Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T (2012) The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3:1078. doi:10.1038/ncomms2090
36. Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, Ren X, Fan GC (2012) Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94:379–390. doi:10.1093/cvr/cvs096
37. Whittaker P, Przyklenk K (1994) Reduction of infarct size in vivo with ischemic preconditioning: mathematical evidence for protection via non-ischemic tissue. Basic Res Cardiol 89:6–15
38. Ye Y, Perez-Polo JR, Qian J, Birnbaum Y (2011) The role of microRNA in modulating myocardial ischemia–reperfusion injury. Physiol Genomics 43:534–542. doi:10.1152/physiolgenomics.00130.2010
39. Yellon DM, Davidson SM (2014) Exosomes: nanoparticles involved in cardioprotection? Circ Res 114:325–332. doi:10.1161/CIRCRESAHA.113.300636
40. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga AG, Fan GC (2010) Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 49:841–850. doi:10.1016/j.yjmcc.2010.08.007